Huisheng International Holdings Limited (HKG:1340)
Hong Kong · Delayed Price · Currency is HKD 0.4750
-0.0100 (-2.06%)
Sep 11, 2026, 3:48 PM HKT
HKG:1340 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 207.51 | 209.57 | 44.28 | 68.3 | 72.95 | 81.29 | |
Revenue Growth | 945.52% | 373.30% | -35.17% | -6.37% | -10.26% | 174.05% |
Cost of Revenue | 205.07 | 207 | 43.74 | 72.94 | 74.21 | 78.69 |
Gross Profit | 2.44 | 2.57 | 0.54 | -4.64 | -1.27 | 2.6 |
Selling, General & Admin | 7.86 | 7.93 | 12.54 | 14.73 | 19.44 | 19.44 |
Operating Expenses | 24.42 | 20.41 | 12.93 | 39.22 | 18.96 | 7.89 |
Operating Income | -21.98 | -17.84 | -12.39 | -43.86 | -20.22 | -5.29 |
Interest Expense | - | - | -0.01 | - | - | -0.78 |
Interest & Investment Income | 0.2 | 0.34 | 2.5 | 1.53 | 1.3 | 1.28 |
Other Non Operating Income (Expenses) | 3.01 | 3.01 | 3 | 25.63 | 10 | 7.85 |
EBT Excluding Unusual Items | -18.77 | -14.49 | -6.9 | -16.7 | -8.92 | 3.07 |
Gain (Loss) on Sale of Investments | -0.29 | -0.78 | 0.69 | -0.7 | 0.29 | 0.78 |
Gain (Loss) on Sale of Assets | - | - | - | -13.14 | -0.39 | -16.76 |
Asset Writedown | - | - | -18.01 | -117.28 | - | -19 |
Other Unusual Items | -0.13 | -0.13 | - | 0.89 | 0.06 | 0.04 |
Pretax Income | -19.18 | -15.39 | -24.21 | -146.94 | -8.96 | -31.88 |
Income Tax Expense | - | - | - | 3.35 | - | - |
Earnings From Continuing Operations | -19.18 | -15.39 | -24.21 | -150.28 | -8.96 | -31.88 |
Minority Interest in Earnings | 0.04 | -0.16 | -0.31 | 5.91 | 3.31 | 0.11 |
Net Income | -19.15 | -15.56 | -24.52 | -144.37 | -5.65 | -31.77 |
Net Income to Common | -19.15 | -15.56 | -24.52 | -144.37 | -5.65 | -31.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 115 | 115 | 113 | 110 | 110 | 110 |
Shares Outstanding (Diluted) | 115 | 115 | 113 | 110 | 110 | 110 |
Shares Change | -0.01% | 2.13% | 2.58% | - | - | - |
EPS (Basic) | -0.17 | -0.13 | -0.22 | -1.31 | -0.05 | -0.29 |
EPS (Diluted) | -0.17 | -0.13 | -0.22 | -1.31 | -0.05 | -0.29 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -373.39 | 6.91 | -28.45 | 284.27 | 139.12 |
Free Cash Flow Per Share | - | -3.24 | 0.06 | -0.26 | 2.58 | 1.26 |
Gross Margin | 1.18% | 1.23% | 1.22% | -6.79% | -1.74% | 3.20% |
Operating Margin | -10.59% | -8.51% | -27.97% | -64.22% | -27.72% | -6.50% |
Profit Margin | -9.23% | -7.42% | -55.38% | -211.39% | -7.74% | -39.08% |
Free Cash Flow Margin | - | -178.17% | 15.60% | -41.65% | 389.69% | 171.13% |
EBITDA | -17.97 | -13.82 | -8.23 | -33.8 | -10.37 | 4.68 |
EBITDA Margin | -8.66% | -6.60% | -18.59% | -49.48% | -14.22% | 5.76% |
D&A For EBITDA | 4.01 | 4.01 | 4.16 | 10.06 | 9.85 | 9.97 |
EBIT | -21.98 | -17.84 | -12.39 | -43.86 | -20.22 | -5.29 |
EBIT Margin | -10.59% | -8.51% | -27.97% | -64.22% | -27.72% | -6.50% |